Back
Day Range
$36.68
$38.27
52-Week Range
$6.42
$39.15
Volume
752,978
50D / 200D Avg
$32.17
/
$19.01
Prev Close
$36.32
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -16.4 | 0.3 |
| P/B | 7.6 | 3.0 |
| ROE % | -39.8 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$49.80
+35.7%
Low: $42.00
High: $59.00
Forward EPS
-$2.38
Est. Revenue
687,429.0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.96
-$0.96 – -$0.96
|
243.02M | 2 |
| FY2029 |
-$2.67
-$2.67 – -$2.67
|
45.35M | 4 |
| FY2028 |
-$2.72
-$3.38 – -$1.10
|
16.52M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -$0.53 | -$0.57 | -7.2% |
| 2025-11-05 | -$0.50 | -$0.50 | 0.0% |
| 2025-08-14 | -$0.53 | -$0.47 | +11.3% |
| 2025-05-08 | -$0.49 | -$0.47 | +4.1% |
| 2025-03-27 | -$0.48 | -$0.43 | +10.4% |
| 2024-11-07 | -$0.40 | -$0.41 | -2.5% |
| 2024-08-07 | -$0.41 | -$0.32 | +22.0% |
| 2024-05-09 | -$0.46 | -$0.35 | +23.9% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -95.28M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-39.83%
ROIC-37.58%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.02
Current Ratio14.67
Interest Coverage0.00
Valuation
P/E Ratio
-16.44
Forward P/EN/A
P/B Ratio7.61
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -119.95M |
| ROE | -39.83% | ROA | -42.44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95.28M |
| ROIC | -37.58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 14.67 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -16.44 | Forward P/E | N/A |
| P/B Ratio | 7.61 | P/S Ratio | N/A |
| PEG Ratio | -0.39 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2868.02 | Fwd Earnings Yield | N/A |
| FCF Yield | -4.83% | ||
| Market Cap | 1.97B | Enterprise Value | 1.90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -119.95M | -86.48M | -69.13M | -55.33M | -26.29M |
| EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 |
| Gross Profit | -546,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -132.76M | -104.18M | -79.95M | -58.93M | -26.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 282.61M | 363.56M | 225.86M | 266.18M | 306.70M |
| Total Liabilities | 23.43M | 20.41M | 21.60M | 8.35M | 4.96M |
| Shareholders' Equity | 259.18M | 343.15M | 204.26M | 257.83M | 301.74M |
| Total Debt | 5.81M | 6.22M | 6.50M | 2.62M | 1.18M |
| Cash & Equivalents | 77.39M | 91.97M | 58.01M | 251.21M | 302.18M |
| Current Assets | 265.45M | 347.46M | 211.67M | 257.29M | 304.06M |
| Current Liabilities | 18.09M | 14.59M | 15.33M | 5.70M | 3.62M |